Sequestration of vecuronium bromide during extremity surgery involving use of a pneumatic tourniquet

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 1 I, 1997, Pages 49-54

  Barnette, R E ^a   Eriksson, L I ^b   Cooney, G F ^a   Brister, N W ^a   Johanson, N ^a   Carlsson, C ^a   Sharma, M L ^c  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

knee prosthesis; neuromuscular nondepolarizing agents; pharmacokinetics; tourniquets; vecuronium bromide

Indexed keywords

VECURONIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL KNEE REPLACEMENT; TOURNIQUET;

EID: 0031053498     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04612.x     Document Type: Article

References (13)

1. Modig J, Kolstad K, Wigren A. Systemic reactions to tourniquet ischaemia. Acta Anaesthesiol Scand 1978: 22: 609-614.
2. Hassan H, Gjessing J, Tomlin PJ. Blood-gas changes following tourniquet release during spinal anaesthesia. Br J Anaesth 1978: 50: 76.
3. Schmitt H, Batz G, Knoll R, Danner U, Brandl M. Plasma level changes of fentanyl and midazolam after release of a prolonged thigh tourniquet. Acta Anaesthesiol Scand 1990: 34: 104-108.
4. Eriksson LI, Lennmarken C, Jensen E, Viby-Mogensen J. Twitch tension and train-of-four ratio during prolonged neuromuscular monitoring at different peripheral temperatures. Acta Anaesthesiol Scand 1991: 34: 247-252.
5. Furuta T, Canfell PC, Castagnoli KP, Sharma ML, Miller RD. Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. J Chromatogr 1988: 427: 41-53.
6. Rocci, Jr. ML, Jusko WJ. LAGRAN program for area and moments in pharmacokinetic analysis. Comput Prog Biomed 1983: 16: 203-216.
7. th edn. Malvern, PA: Lea and Febiger, 1991.
8. Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA. Pharmacokinetics of ORG NC 45 (norcuron) in patients with and without renal failure. Br J Anaesth 1981: 53: 1049-1052.
9. Lebrault C, Berger JL, D'Hollander AA, Gomeni R, Henzel D, Duvaldestin P. Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiology 1985: 62: 601-605.
10. Dailey PA, Fisher DM, Shnider SM, Baysinger CL, Shinohara Y, Miller RD, et al. Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section. Anesthesiology 1984: 60: 569-574.
11. Bencini AF, Scaf AHJ, Sohn YJ, Meistelman C, Lienhart A, Kersten UW, et al. Disposition and urinary excretion of ve-curonium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 1986: 65: 245-251.
12. Ducharme J, Varin F, Bevan DR, Donati F. Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters. Clin Pharmacokinet 1993: 24: 507-518.
13. ndedn. Philadelphia: Lea and Febiger, 1989.